Sun Pharma Secures Ex-US, China Rights To Cholesterol Drug Lerodalcibep
Sun Pharmaceutical Industries and LIB Therapeutics Inc. announced an exclusive licensing agreement granting the Indian pharma major rights to commercialise and manufacture lerodalcibep worldwide, excluding the United States and China.
